针对宿主通道和病毒素:SARS-CoV-2治疗的有希望的策略
Mona Fani1,2, Maryam Moossavi3, Hasan Bakhshi1
1Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Future virology
|September 13, 2023
概括
通道阻断剂 (CCB) 通过抑制对SARS-CoV-2复制和炎症至关重要的通道来治疗COVID-19具有前景. 与CCB一起准病毒素可能进一步限制病毒传播.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染涉及复杂的宿主-病原体相互作用.
- 在SARS-CoV-2感染期间,离子 (Ca2+) 在病毒进入和炎症反应中发挥着关键作用.
- 病毒蛋白是复制和致病性至关重要的病毒蛋白,使它们成为潜在的治疗点.
研究的目的:
- 探索通道阻断剂 (CCB) 作为对抗SARS-CoV-2的治疗策略的潜力.
- 研究通道在病毒融合和炎症途径中的双重作用.
- 评估CCBs和病毒抑制剂在COVID-19治疗中的联合治疗潜力.
主要方法:
- 对SARS-CoV-2中通道功能的现有证据的审查.
- 分析Ca2+在病毒复制和宿主炎症反应中的作用.
- 评估病毒素作为抗病毒点.
主要成果:
- 对于SARS-CoV-2的融合过程,Ca2+的流入是必要的.
- 与SARS-CoV-2感染相关的炎症因素是由Ca2+水平调节的.
- 抑制宿主通道和病毒病毒素可以阻止病毒的传播.
结论:
- 通道阻断剂 (CCB) 是COVID-19的可行的治疗选择.
- 针对宿主通道和病毒病毒素,为抗病毒疗法提供了一种有前途的双重方法.
- 对CCB和病毒抑制剂的进一步研究是有效的SARS-CoV-2管理的必要条件.
相关概念视频
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...